Vitamin d trial aims to stop dangerous pregnancy complication from recurring
NCT ID NCT07288801
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking vitamin D supplements can prevent preeclampsia from returning in pregnant women who had it before. About 146 women will be randomly assigned to take either vitamin D or a placebo pill until 36 weeks of pregnancy. Researchers will track blood pressure and urine protein to see if vitamin D reduces the risk of recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nishtar Medical University and Hospital
RECRUITINGMultan, Punjab Province, 60000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Could a smart ring unlock secrets of pregnancy health?
- Could Video-Led pelvic exercises redefine prenatal care?